Poonawalla Family's Global 6500 lands in Navi Mumbai as Serum Institute expands vaccine push

Poonawalla Family's Bombardier Global 6500, tail number VT-CCA, was tracked flying from London Stansted Airport (EGSS) to Navi Mumbai International Airport (VANM) on September 14, 2026, completing the 9-hour, 21-minute journey at a maximum altitude of 41,025 feet. The aircraft's arrival at the newly operational Navi Mumbai airport—a facility designed to ease congestion at Mumbai's older airport—marks a significant logistical shift for the family's travel patterns, given their home base at Pune Airport (VAPO).

If aboard, Poonawalla Family would arrive the same week that Serum Institute of India, the world's largest vaccine manufacturer by doses, is reportedly ramping up production of its dengue vaccine, Qdenga, for global distribution. Per a Reuters report earlier this month, the company is expanding its manufacturing capacity to meet demand from multiple countries, including Brazil and Indonesia, with the vaccine being a key revenue driver for the family's $27 billion fortune. The timing of the flight, landing in Navi Mumbai rather than Pune, suggests a possible business engagement in the financial capital, where Serum's corporate affairs and government liaisons are often conducted.

The flight follows a pattern of recent movements by the same owner, including a September 9 hop from London Heathrow to Pune, and a September 5 leg from Mumbai to London. The family's fleet, which includes a Bombardier Global 6000 and a Gulfstream G550, is operated by Poonawalla Aviation Pvt. Ltd., established in 2005. The choice of Stansted as the departure point—a hub for private aviation—aligns with the family's frequent travel to London, where they maintain a residence and where Adar Poonawalla, the CEO, has been known to meet with international partners and investors.

This particular flight, however, stands out for its destination: Navi Mumbai International Airport, which only began full operations earlier this year. The airport's proximity to the Serum Institute's headquarters in Pune, about a two-hour drive, makes it a convenient entry point for the family. Should Poonawalla Family have been aboard, the landing would coincide with the ongoing monsoon season in India, a period when vaccine distribution and cold-chain logistics are critical. The aircraft's range of over 11,000 kilometers means the London-to-Navi Mumbai leg is well within its capabilities, and the family's use of a newer Global 6500 suggests a preference for cutting-edge efficiency.

Whether the flight was purely business or included a personal component, the movement underscores the family's operational rhythm: shuttling between global vaccine hubs and their Indian base. As the world's largest vaccine maker continues to navigate post-pandemic demand and new product launches, the skies over Pune and Navi Mumbai are likely to see more of this aircraft's distinctive tail number. For now, the landing at VANM is just another data point in a pattern of purposeful travel, one that speaks to the family's dual focus on global health and domestic expansion.